Internal Medicine Alert – September 15, 2006
September 15, 2006
View Issues
-
Low-Dose Corticosteroid Use Safe in Rheumatoid Arthritis
An impressive team of authors from seven European countries and the United States conducted a systematic review of the scientific literature on the risks and side effects of low-dose corticosteroids in the treatment of chronic rheumatoid arthritis. -
Subclinical Hypothyroidism: To Treat or Not to Treat?
The cardiovascular system is one of the principal targets of thyroid hormone. -
How Long is Long Enough?
Three days of amoxicillin is as effective as five for mild-to-moderately severe community-acquired pneumonia. -
OTC Sunscreen Cream (Anthelios SX Cream)
The FDA has approved a unique otc sunscreen that combines three active ingredients including a new molecular entity, ecamsule. -
Clinical Briefs By Louis Kuritzky, MD
Defining hypogonadism (HGO) remains a remarkably difficult challenge. The 'normal' range for testosterone (TES) in adult males is typically 350-1050 ng/dL. -
ECG Review: Just Before the Run
The two non-sequential tracings in the Figure were interpreted as showing sinus tachycardia interrupted by runs of VT (ventricular tachycardia). Do you agree? -
Raloxifene's Role for Estrogen- and Age-Related Problems
What is the role of raloxifene for the treatment of osteoporosis and breast cancer prevention? Raloxifene is a selective estrogen-receptor modulator similar to tamoxifen.